Michael Barbella, Managing Editor05.06.24
Vista.ai has appointed Daniel Hawkins as president and CEO.
“We invested in Vista early on as it has the potential to transform healthcare access and costs,” Khosla Ventures Partner Bruce Armstrong said. “We are thrilled to have Daniel at the helm of this company. His demonstrated experience in developing new markets, establishing product-market fit and driving foundational go-to-market strategies and results make him the ideal leader.”
A serial entrepreneur and leader with more than 30 years of medtech experience, Hawkins has held marketing, business development, and managerial roles in established and early-stage companies including Guidant (Abbott vascular), Intuitive Surgical where he drove initial market creation for the DaVinci surgical robot, and Shockwave Medical, where he invented the core technology and served as CEO. A prolific inventor, he is named on more than160 medical device and digital health patents and applications.
"I am excited to join the team responsible for Vista’s AI-based MRI technology. This is an important time for the company and I’m looking forward to leading our efforts to bring this much needed technology to market,” Hawkins stated. “Over 40 million MRI scans are performed each year in the U.S. alone and wait times to receive a scan are often very long and scan quality can be quite variable. Most often, this is due to systemic shortages in MRI technicians with particularly acute needs for those trained to conduct complex scans in specialties like cardiac, brain, and spine. Vista software is designed to eliminate those issues, enabling completion of high-quality complex and specialty scans by virtually any MRI technician, faster, better and more consistently than before. The team at Vista is looking forward to bringing this capability to providers and patients worldwide.”
Daniel joins Vista.ai following U.S. Food and Drug Administration clearance and confirmatory early commercialization of its initial cardiac MRI (CMR)-focused product. Over time, the company plans to launch brain, spine, and other indications to its suite of artificial intelligence-driven MRI capability.
Vista.ai developed One Click MRI—AI-guided software that automates MRI exams so any clinician can perform scans quickly, accurately, and affordably. The company is headquartered in Palo Alto, Calif.
“We invested in Vista early on as it has the potential to transform healthcare access and costs,” Khosla Ventures Partner Bruce Armstrong said. “We are thrilled to have Daniel at the helm of this company. His demonstrated experience in developing new markets, establishing product-market fit and driving foundational go-to-market strategies and results make him the ideal leader.”
A serial entrepreneur and leader with more than 30 years of medtech experience, Hawkins has held marketing, business development, and managerial roles in established and early-stage companies including Guidant (Abbott vascular), Intuitive Surgical where he drove initial market creation for the DaVinci surgical robot, and Shockwave Medical, where he invented the core technology and served as CEO. A prolific inventor, he is named on more than160 medical device and digital health patents and applications.
"I am excited to join the team responsible for Vista’s AI-based MRI technology. This is an important time for the company and I’m looking forward to leading our efforts to bring this much needed technology to market,” Hawkins stated. “Over 40 million MRI scans are performed each year in the U.S. alone and wait times to receive a scan are often very long and scan quality can be quite variable. Most often, this is due to systemic shortages in MRI technicians with particularly acute needs for those trained to conduct complex scans in specialties like cardiac, brain, and spine. Vista software is designed to eliminate those issues, enabling completion of high-quality complex and specialty scans by virtually any MRI technician, faster, better and more consistently than before. The team at Vista is looking forward to bringing this capability to providers and patients worldwide.”
Daniel joins Vista.ai following U.S. Food and Drug Administration clearance and confirmatory early commercialization of its initial cardiac MRI (CMR)-focused product. Over time, the company plans to launch brain, spine, and other indications to its suite of artificial intelligence-driven MRI capability.
Vista.ai developed One Click MRI—AI-guided software that automates MRI exams so any clinician can perform scans quickly, accurately, and affordably. The company is headquartered in Palo Alto, Calif.